XML 36 R19.htm IDEA: XBRL DOCUMENT
v3.24.0.1

SHARE-BASED COMPENSATION PLANS | 12 Months Ended
--- | ---
Dec. 31, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract] |
SHARE-BASED COMPENSATION PLANS | Our employee share-based compensation plans consist of our employee stock purchase plan and our long-term incentive plan. Effective April 27, 2022, our shareholders approved the Deluxe Corporation 2022 Stock Incentive Plan, simultaneously terminating our previous plan. Under the current plan, 2.5 million shares of common stock plus any shares released as a result of the forfeiture or termination of awards issued under our prior plan are reserved for issuance, with 2.4 million shares remaining available for issuance as of December 31, 2023. Under our current and previous plans, we have granted non-qualified stock options, restricted stock units and performance share unit awards. Our current plan also allows for the issuance of restricted stock and stock appreciation rights, none of which were outstanding as of December 31, 2023. Our policy regarding the recognition of compensation expense for employee share-based awards can be found in Note 1. The following amounts were recognized in our consolidated statements of income for share-based compensation awards for the years ended December 31:
(in thousands) |  | 2023 |  | 2022 |  | 2021
Restricted stock units |  | $ | 14,092 |  |  | $ | 16,632 |  |  | $ | 20,407 |
Performance share unit awards |  | 4,127 |  |  | 3,840 |  |  | 4,338 |
Stock options |  | 1,845 |  |  | 2,665 |  |  | 4,187 |
Employee stock purchase plan |  | 461 |  |  | 539 |  |  | 545 |
Total share-based compensation expense |  | $ | 20,525 |  |  | $ | 23,676 |  |  | $ | 29,477 |
Income tax benefit |  | $ | (7,408) |  |  | $ | (6,853) |  |  | $ | (7,714) |
As of December 31, 2023, the total compensation expense for unvested awards not yet recognized in our consolidated statements of income was $22,213, net of the effect of estimated forfeitures. This amount is expected to be recognized over a weighted-average period of 1.9 years. Non-qualified stock options – All options allow for the purchase of shares of common stock at prices equal to the stock's market value at the date of grant. Options become exercisable beginning 1 year after the grant date, with one-fourth vesting each year over 4 years. Options granted under the current plan may be exercised up to 10 years following the grant date. Awards granted prior to 2019 have a 7 year life. No stock options were granted during 2023 or 2022. The weighted-average grant-date fair value of options granted was $11.57 per option for 2021. The following weighted-average assumptions were used in the Black-Scholes option pricing model to determine the fair value of these stock option grants:
|  |  |  |  |  | 2021
Risk-free interest rate |  |  |  |  |  | 0.7 | %
Dividend yield |  |  |  |  |  | 2.9 | %
Expected volatility |  |  |  |  |  | 42.0 | %
Weighted-average option life (in years) |  |  |  |  |  | 4.8
The risk-free interest rate for periods within the expected option life is based on the U.S. Treasury yield curve in effect at the grant date. The dividend yield is estimated over the expected life of the option based on historical dividends paid. Expected volatility is based on the historical volatility of our stock over the most recent historical period equivalent to the expected life of the option. The expected option life is the average length of time over which we expect the employee groups will exercise their options, based on historical experience with similar grants. Each option is convertible into 1 share of common stock upon exercise. Information regarding options issued under the current and all previous plans was as follows:
|  | Number of options (in thousands) |  | Weighted-average exercise price per option |  | Aggregate intrinsic value (in thousands) |  | Weighted-average remaining contractual term (in years)
Outstanding, December 31, 2022 |  | 1,732 |  |  | $ | 44.77 |  |  |  |  |
Forfeited or expired |  | (352) |  |  | 44.24 |  |  |  |  |
Outstanding, December 31, 2023 |  | 1,380 |  |  | 44.91 |  |  | $ | — |  |  | 4.9
Exercisable at December 31, 2023 |  | 1,158 |  |  | 45.79 |  |  | $ | — |  |  | 4.5
The intrinsic value of a stock award is the amount by which the fair value of the underlying stock exceeds the exercise price of the award. The total intrinsic value of options exercised was $510 for 2021. Restricted stock units – We grant restricted stock unit awards to all North American employees, and during 2021 and 2020, we paid a portion of employee bonuses in restricted stock units. We also grant certain other restricted stock unit awards under our long-term incentive plan. These awards generally vest over periods of 3 years or 4 years. Additionally, certain management employees have the option to receive a portion of their bonus payment in the form of restricted stock units. If employees subsequently choose to leave the company, these bonus awards are settled in cash. Cash payments to settle these awards were not material during the past 3 years. In addition to awards granted to employees, non-employee members of our board of directors can elect to receive all or a portion of their fees in the form of restricted stock units. Each restricted stock unit is convertible into 1 share of common stock upon completion of the vesting period. Information regarding our restricted stock units was as follows:
|  | Number of units (in thousands) |  | Weighted-average grant date fair value per unit |  | Weighted-average remaining vesting period (in years)
Outstanding at December 31, 2022 |  | 1,045 |  |  | $ | 34.10 |  |  |
Granted |  | 987 |  |  | 18.98 |  |  |
Vested |  | (475) |  |  | 35.77 |  |  |
Forfeited |  | (336) |  |  | 25.44 |  |  |
Outstanding at December 31, 2023 |  | 1,221 |  |  | 23.34 |  |  | 2.4
Of the awards outstanding at December 31, 2023, 37 thousand restricted stock units with a value of $798 were included in accrued liabilities and other non-current liabilities on the consolidated balance sheet. As of December 31, 2023, these units had a fair value of $21.45 per unit and a weighted-average remaining contractual term of 4 months. The fair market value of restricted stock units that vested was $8,538 for 2023, $13,602 for 2022 and $16,646 for 2021. Performance share unit awards – Our performance share unit awards have a 3 year vesting period. Shares will be issued at the end of the vesting period if performance targets relating to revenue and total shareholder return are achieved. If employment is terminated for any reason prior to the 1 year anniversary of the commencement of the performance period, the award is forfeited. On or after the 1 year anniversary of the commencement of the performance period, a pro-rata portion of the shares awarded at the end of the performance period is issued in the case of qualified retirement, death, disability, involuntary termination without cause or resignation for good reason, as defined in the agreement. The following weighted-average assumptions were used in the Monte Carlo simulation model in determining the fair value of market-based performance share units granted:
|  | 2023 |  | 2022 |  | 2021
Risk-free interest rate |  | 4.4 | % |  | 1.8 | % |  | 0.3 | %
Dividend yield |  | 6.1 | % |  | 3.7 | % |  | 4.4 | %
Expected volatility |  | 54.3 | % |  | 54.9 | % |  | 55.6 | %
The risk-free interest rate for periods within the expected award life is based on the U.S. Treasury yield curve in effect at the grant date. The dividend yield is estimated over the expected life of the award based on historical dividends paid. Expected volatility is based on the historical volatility of our stock over the expected life of the award. Information regarding unvested performance share units was as follows:
|  | Performance share units (in thousands) |  | Weighted-average grant date fair value per unit |  | Weighted-average remaining contractual term (in years)
Unvested at December 31, 2022 |  | 461 |  |  | $ | 34.35 |  |  |
Granted(1) |  | 298 |  |  | 18.34 |  |  |
Forfeited |  | (235) |  |  | 27.12 |  |  |
Unvested at December 31, 2023 |  | 524 |  |  | 28.50 |  |  | 1.5
(1) Reflects awards granted assuming achievement of performance goals at target. Employee stock purchase plan – During 2023, 196 thousand shares were issued under this plan at prices ranging from $12.61 to $15.77. During 2022, 149 thousand shares were issued under this plan at prices ranging from $15.62 to $25.59. During 2021, 108 thousand shares were issued under this plan at prices ranging from $18.84 to $37.32.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration